Skip to main content
Toggle navigation
Login
Search
Home
Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Email
Tweet
ZEEL S. SHAH, PhD (she/her/hers)
Research Investigator
Bristol Myers Squibb
Poster(s):
(M-099) Advancing Drug Development in Relapsed and Refractory Multiple Myeloma (RRMM): Assessing the Safety and Efficacy Landscape Utilizing Model-Based Meta-Analysis
Monday, November 11, 2024
7:00 AM – 5:00 PM
MST
Email ZEEL
